1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        By State of Finished Product

1.3.2        By Content

1.3.3        By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Pharmaceutical Fill and Finish Outsourcing Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           Pharmaceutical Fill and Finishing Outsourcing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Investment in Biopharmaceutical Sector

5.1.2        Elevating Demand for Biologics

5.2         Market Restraints

5.2.1        Upsurging Competition in Contract Manufacturing Industry

5.3         Market Opportunities

5.3.1        Growing Market for Biotherapeutics

5.4         Future Trends

5.4.1        Rising Market Consolidation

5.5         Impact Analysis

6.           Pharmaceutical Fill and Finish Outsourcing Market– North America Analysis

6.1         North America Pharmaceutical Fill and Finish Outsourcing Market, By Geography - Forecast and Analysis

7.           North America Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028– by State of the Finished Product

7.1         Overview

7.2         North America Pharmaceutical Fill and Finish Outsourcing Market, By State of the Finished Product, 2020 & 2028 (%)

7.3         Solids

7.3.1        Overview

7.3.2        Solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Semisolids

7.4.1        Overview

7.4.2        Semi-solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Liquids

7.5.1        Overview

7.5.2        Liquids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

8.           Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 – Content

8.1         Overview

8.2         North America Pharmaceutical Fill and Finish Outsourcing Market Share by Content - 2020 & 2028 (%)

8.3         Organic Substances Isolated from Animal Origin

8.3.1        Overview

8.3.2        Organic Substances Isolated from Animal Origin: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Organic Substances Isolated from Microorganisms

8.4.1        Overview

8.4.2        Organic Substances Isolated from Microorganisms: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

8.5         Inorganic Substances

8.5.1        Overview

8.5.2        Inorganic Substances: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

9.           Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1         North America: Pharmaceutical Fill and Finish Outsourcing Market

9.1.1        Overview

9.1.2        North America: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3        North America: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.4        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

9.1.5        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Country, 2021 & 2028 (%)

9.1.5.1          US: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1          Overview

9.1.5.1.2          US: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3          US: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.5.1.4          US: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

9.1.5.2          Canada: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1          Overview

9.1.5.2.2          Canada: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3          Canada: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.5.2.4          Canada: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

9.1.5.3          Mexico: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1          Overview

9.1.5.3.2          Mexico: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3          Mexico: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products, 2019–2028 (US$ Million)

9.1.5.3.4          Mexico: Pharmaceutical Fill and Finish Outsourcing Market, by Content, 2019–2028 (US$ Million)

10.        Impact Of COVID-19 Pandemic on Pharmaceutical Fill and Finish Outsourcing Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Pharmaceutical Fill and Finish Outsourcing Market–Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Pharmaceutical Fill and Finish Outsourcing Market (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      Abbott

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Sun Pharmaceutical Industries Ltd

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Piramal Enterprises Ltd.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      MabPlex International Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      WOCKHARDT

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Cytovance Biologics

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Thermo Fisher Scientific Inc. (Patheon N.V)

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Boehringer Ingelheim International GmbH

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 2.             North America Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028  (US$ Million)

Table 5.             Canada: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028  (US$ Million)

Table 7.             Mexico: Pharmaceutical Fill and Finish Outsourcing Market, by State of Finished Products – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico Pharmaceutical Fill and Finish Outsourcing Market, by Content– Revenue and Forecast to 2028  (US$ Million)

Table 9.             Organic Developments in the Pharmaceutical Fill and Finish Outsourcing Market

Table 10.          Inorganic Developments in the Pharmaceutical Fill and Finish Outsourcing Market

Table 11.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Pharmaceutical Fill and Finish Outsourcing Market Segmentation

Figure 2.           North America Pharmaceutical Fill and Finish Outsourcing Market Overview

Figure 3.           Liquid Segment Held Largest Share of State of Finished Product Segment in Pharmaceutical Fill and Finish Outsourcing Market

Figure 4.           Canada is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Pharmaceutical Fill and Finish Outsourcing Market, Industry Landscape

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Number of Approvals for NDA & BLA (2015 to 2020)

Figure 9.           Impact Analysis of Drivers and Restraints Pertaining to Pharmaceutical Fill and Finishing Outsourcing Market

Figure 10.        North America Pharmaceutical Fill and Finish Outsourcing Market – By Geography Forecast and Analysis – 2020 - 2028

Figure 11.        North America Pharmaceutical Fill and Finish Outsourcing Market, by State of the Finished Product, 2020 & 2028 (%)

Figure 12.        Solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Semi-solids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Liquids: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        North America Pharmaceutical Fill and Finish Outsourcing Market Share by Content - 2020 & 2028 (%)

Figure 16.        Organic Substances Isolated from Animal Origin: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Organic Substances Isolated from Microorganisms: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.        Inorganic Substances: Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 20.        North America Pharmaceutical Fill and Finish Outsourcing Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America: Pharmaceutical Fill and Finish Outsourcing Market, by Country, 2021 & 2028 (%)

Figure 22.        US: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Canada: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Mexico: Pharmaceutical Fill and Finish Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 26.        Growth Strategies in the Pharmaceutical Fill and Finish Outsourcing Market (%)